Literature DB >> 19442097

Diabetes, oxidative stress, nitric oxide and mitochondria function.

Malou Friederich1, Peter Hansell, Fredrik Palm.   

Abstract

The role of altered mitochondria function has recently emerged as an important mechanism for the development of diabetic complications. Altered mitochondria function has also been implicated in the ageing process, defective insulin secretion, hypertension, arteriosclerosis, ischemia-reperfusion injury and apoptosis. Normally, the mitochondria are associated with ATP production using primarily pyruvate as the substrate, but recent reports indicate that tissue specific preferences exist. Also, the mitochondria are a substantial source of superoxide production, preferentially during states of elevated intracellular glucose concentrations. The mitochondria function is regulated by several factors including nitric oxide, oxidative stress, mammalian target of rapamycin, ADP and P(i) availability, which result in a complex regulation of ATP production and oxygen consumption, but also superoxide generation. These factors seem to be tissue specific, which warrants a more diverse mechanistic model applying to that specific tissue or cell type. This review presents the basic functions of the mitochondria and focuses on the complex interplay between oxidative stress, nitric oxide and uncoupling proteins in regulating mitochondria function with special focus on diabetes-induced alterations occurring on the mitochondria level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442097     DOI: 10.2174/157339909788166800

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  43 in total

1.  Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria.

Authors:  Brian A Stanley; Vidhya Sivakumaran; Sa Shi; Iain McDonald; David Lloyd; Walter H Watson; Miguel A Aon; Nazareno Paolocci
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 2.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

Review 3.  SERCA control of cell death and survival.

Authors:  Elie R Chemaly; Luca Troncone; Djamel Lebeche
Journal:  Cell Calcium       Date:  2017-07-12       Impact factor: 6.817

4.  Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes.

Authors:  Carlo G Tocchetti; Brian A Stanley; Vidhya Sivakumaran; Djahida Bedja; Brian O'Rourke; Nazareno Paolocci; Sonia Cortassa; Miguel A Aon
Journal:  Clin Sci (Lond)       Date:  2015-06-11       Impact factor: 6.124

Review 5.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

Review 6.  Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.

Authors:  Alice Biosa; Tiago F Outeiro; Luigi Bubacco; Marco Bisaglia
Journal:  Mol Neurobiol       Date:  2018-03-28       Impact factor: 5.590

Review 7.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

Review 8.  The proximal tubule in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 9.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

10.  Hypoxia-inducible factor-1α (HIF-1α) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia.

Authors:  Juan R Zapata-Morales; Othir G Galicia-Cruz; Martha Franco; Flavio Martinez Y Morales
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.